Journal
CANCERS
Volume 15, Issue 10, Pages -Publisher
MDPI
DOI: 10.3390/cancers15102676
Keywords
MALDI imaging; biopsy; multimodal; spatialomics; infrared; immunohistochemistry; co-registration; mass spectrometry
Categories
Ask authors/readers for more resources
The current focus of cancer pathology diagnosis is on histopathological analysis using stained tissue and immunohistochemistry of marker proteins. However, spatial omics imaging is an emerging diagnostic technology for identifying and classifying different cancer types. To address the need for preserving tissue-specific metabolomic states, we developed a device and corresponding workflows for multimodal spatial omics analysis of fresh-frozen needle biopsies, allowing for a spatial comparison between spectral profiles and tissue histology without the need for an extra biopsy.
The complex molecular alterations that underlie cancer pathophysiology are studied in depth with omics methods using bulk tissue extracts. For spatially resolved tissue diagnostics using needle biopsy cores, however, histopathological analysis using stained FFPE tissue and the immunohistochemistry (IHC) of a few marker proteins is currently the main clinical focus. Today, spatial omics imaging using MSI or IRI is an emerging diagnostic technology for the identification and classification of various cancer types. However, to conserve tissue-specific metabolomic states, fast, reliable, and precise methods for the preparation of fresh-frozen (FF) tissue sections are crucial. Such methods are often incompatible with clinical practice, since spatial metabolomics and the routine histopathology of needle biopsies currently require two biopsies for FF and FFPE sampling, respectively. Therefore, we developed a device and corresponding laboratory and computational workflows for the multimodal spatial omics analysis of fresh-frozen, longitudinally sectioned needle biopsies to accompany standard FFPE histopathology of the same biopsy core. As a proof-of-concept, we analyzed surgical human liver cancer specimens using IRI and MSI with precise co-registration and, following FFPE processing, by sequential clinical pathology analysis of the same biopsy core. This workflow allowed for a spatial comparison between different spectral profiles and alterations in tissue histology, as well as a direct comparison for histological diagnosis without the need for an extra biopsy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available